Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

S&P/ASX 200 To Open Lower, 3 ASX Shares To Watch

The S&P/ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open slightly lower today, despite the USA’s S&P 500 Index (.INX) rising 0.70% on Monday.

The S&P/ASX 200 (INDEXASX: XJO)(^AXJO) is expected to open slightly lower today, despite the USA’s S&P 500 Index (.INX) rising 0.70% on Monday.

Here are the data points:

Australian Dollar ($A) (AUDUSD): 71.48 US cents

Dow Jones (DJI): up 0.42%

Oil (WTI): $US48.66 per barrel

Gold: $US1,289 per ounce

Sharemarket News

In sharemarket news, biotechnology business Telix Pharmaceuticals Ltd (ASX: TLX) announced that it is going to accelerate its prostate cancer therapy program after looking at the historical academic data for huJ591 from its recent acquired business, Atlab Pharma SAS.

Analysis of the data and independent monitoring by a third party, Clinical Research Organization, is strongly supportive of taking huJ591 into a Phase III study under certain dosing conditions called fractionated dosing, subject to regulatory approval. Telix is potentially able to accelerate its antibody-directed prostate cancer radiotherapy program by approximately two years.

Telix CEO Dr Christian Behrenbruch said: “Given the considerable momentum around prostate radiotherapy, we feel it is prudent to pursue a strategy that enables us to get to Phase III as soon as possible.”

[ls_content_block id=”15758″ para=”paragraphs”]

In other news, infant formula business Wattle Health Australia Ltd (ASX: WHA) has reported that Blend and Pack has successfully renewed its Certification and Accreditation Administration of the Peoples Republic of China (CNCA) for the manufacture of infant formula.

Blend and Pack is Australia’s largest independent manufacturer of nutritional dairy products and one of 15 CNCA accredited for infant formula in Australia. Wattle Health is a shareholder of B&P and has secured the first brand slot for accreditation.

RAIZ Invest Ltd (ASX: RZI), formerly known as Acorns in Australia, announced that its monthly active customers increased by 0.2% to 175,345 at the end of December 2018.

The micro-investment business allows users to round up their payments to add to their Raiz investment account.

Raiz reported that its total funds under management (FUM) decreased by 1.2% to $254 million during December due to falls in global markets.

Raiz Invest CEO George Lucas said: “We remain focused on our growth strategy, for which we remain well funded.”

[ls_content_block id=”14948″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content